Blood metabolic biomarkers and colorectal cancer risk: results from large prospective cohort and Mendelian randomisation analyses
Fangcheng Yuan(Vanderbilt University Medical Center), Wei Zheng(Vanderbilt University), Guochong Jia(Vanderbilt University Medical Center), Shuai Xu(Washington University in St. Louis), Kui Deng(Vanderbilt University Medical Center), Danxia Yu(Vanderbilt University Medical Center), Wanqing Wen(Vanderbilt University Medical Center), Jirong Long(Vanderbilt University Medical Center), Xiao Shu(Vanderbilt University Medical Center), Valerie Gunchick(Vanderbilt University Medical Center)
Cited by 9
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
|Nature Genetics|2009|724